Stay updated on Alpha Study: Afatinib & Pembrolizumab in HNSCC Clinical Trial

Sign up to get notified when there's something new on the Alpha Study: Afatinib & Pembrolizumab in HNSCC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Alpha Study: Afatinib & Pembrolizumab in HNSCC Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    10 days ago
    No Change Detected
  3. Check
    17 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.6.5, replacing v3.6.4, as a software version update. It does not modify the study details, eligibility criteria, or other user-facing content.
    Difference
    0.1%
    Check dated 2026-08-08T16:53:56.000Z thumbnail image
  4. Check
    24 days ago
    No Change Detected
  5. Check
    32 days ago
    Change Detected
    Summary
    The revision label on the page has been updated from v3.6.3 to v3.6.4, indicating a small underlying update to the site. The visible study details and navigation remain unchanged.
    Difference
    0.1%
    Check dated 2026-07-25T08:21:51.000Z thumbnail image
  6. Check
    53 days ago
    Change Detected
    Summary
    The page's revision tag was updated from v3.6.2 to v3.6.3, indicating a minor metadata update to the page.
    Difference
    0.1%
    Check dated 2026-07-03T22:46:31.000Z thumbnail image
  7. Check
    60 days ago
    Change Detected
    Summary
    The page now shows an updated Revision: v3.6.2, replacing the previous v3.6.0, signaling a minor platform update to the study details page.
    Difference
    0.1%
    Check dated 2026-06-26T23:19:16.000Z thumbnail image
  8. Check
    74 days ago
    Change Detected
    Summary
    Recruitment status updated to closed for the study. New help/navigation sections were added (How to Read a Study Record, Common Questions, How to Join a Study); the Intervention/Treatment heading was standardized, and the site revision note updated to v3.6.0.
    Difference
    0.5%
    Check dated 2026-06-12T16:38:22.000Z thumbnail image
  9. Check
    81 days ago
    Change Detected
    Summary
    The page's revision label was updated from v3.5.4 to v3.5.5, signaling a new version of the page or its template. This update appears to be a metadata/versioning change rather than a modification to the study content or data presented.
    Difference
    0.1%
    Check dated 2026-06-05T12:15:28.000Z thumbnail image

Stay in the know with updates to Alpha Study: Afatinib & Pembrolizumab in HNSCC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Alpha Study: Afatinib & Pembrolizumab in HNSCC Clinical Trial page.